AM_REV_0061: Expanding the applicability conditions of AM0034 including the production of caprolactam and the use of NSCR devices (in the baseline scenario) besides the abatement technology implemented in the project activity.

Reference AM_REV_0061
Submitted by DNV (10 Aug 07)
Request F-CDM-AM-Rev (227 KB)
PDD PDD (734 KB)
Draft AM Draft AM (222 KB)
Methodologies
Final response Final response (118 KB)
Historic statusesNo status history available